Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 556–570 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4868 PICALM Gene Genetic Test for Immunological & Dermatologic Disorders This test analyzes the PICALM gene for pathogenic variants linked to immunological, dermatologic, and oncological disorders.	Peripheral whole blood	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PICALM gene", "Full coding region and splice sites of PICALM"] Parameters [] Preparation ["No fasting required.", "Provide a three-generation family pedigree.", "Disclose all current medications during genetic counseling."] Indications ["Suspected immunological disorder", "Suspected dermatologic condition", "Cancer predisposition assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Z13.89 Clinical summary This test analyzes the PICALM gene for pathogenic variants linked to immunological, dermatologic, and oncological disorders.
TEST-5408 PIEZO2 Gene Distal Arthrogryposis Type 3 (DA3) Genetic Test This test identifies pathogenic variants within the PIEZO2 gene associated with Distal Arthrogryposis Type 3 (Gordon Syndrome). It utilizes full-gene Next-Generation Sequencing for...	Peripheral Whole Blood (EDTA) or FTA Card Dried Blood Spot	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PIEZO2 gene", "Single-nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy-number alterations"] Parameters [{"name": "Analytical Sensitivity", "reference_range": ">99.9% for SNVs, >98% for small indels"}, {"name": "Mean Sequencing Depth", "reference_range": ">30x"}] Preparation ["No specific fasting required", "Inform lab of any medications being taken"] Indications ["Suspected diagnosis of Distal Arthrogryposis Type 3 (Gordon Syndrome)", "Family history of DA3", "Carrier screening", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81313-4 ICD-10: Q74.3, Q68.8 Clinical summary This test identifies pathogenic variants within the PIEZO2 gene associated with Distal Arthrogryposis Type 3 (Gordon Syndrome). It utilizes full-gene Next-Generation Sequencing for comprehensive analysis.
TEST-2614 PIEZO2 Gene Marden-Walker Syndrome Genetic Test This test identifies pathogenic variants in the PIEZO2 gene associated with Marden-Walker syndrome.	Peripheral Whole Blood or FTA Card	21 to 28 days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in PIEZO2 gene coding regions", "Pathogenic variants in PIEZO2 gene splice junctions"] Parameters [] Preparation [] Indications ["Suspected Marden-Walker syndrome", "Family history of Marden-Walker syndrome", "Genetic counseling for recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 94268-2 ICD-10: Q87.0 Clinical summary This test identifies pathogenic variants in the PIEZO2 gene associated with Marden-Walker syndrome.
TEST-2719 PIGW Gene Hyperphosphatasia with Mental Retardation Syndrome Type 5 (HPMRS5) Genetic Test This genetic test identifies pathogenic mutations in the PIGW gene associated with Hyperphosphatasia with Mental Retardation Syndrome Type 5 (HPMRS5). It helps confirm the diagnosi...	Peripheral Whole Blood, Extracted DNA, or FTA Card Sample	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PIGW gene", "Point mutations", "Small indels", "Copy number variants"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed prior to sample collection"] Indications ["Clinical suspicion of Hyperphosphatasia with Mental Retardation Syndrome Type 5 (HPMRS5)", "Confirmation of diagnosis in patients with relevant clinical features"] Measurement technique Confirm with laboratory Codes LOINC: 81263-4 ICD-10: E83.39, Q87.89 Clinical summary This genetic test identifies pathogenic mutations in the PIGW gene associated with Hyperphosphatasia with Mental Retardation Syndrome Type 5 (HPMRS5). It helps confirm the diagnosis in individuals with suggestive clinical features.
TEST-1231 PIK3CA Gene Analysis by Next‑Generation Sequencing (NGS) Test This test evaluates the PIK3CA gene for somatic mutations using Next-Generation Sequencing (NGS). It identifies variants associated with solid tumours and overgrowth syndromes.	Peripheral Whole Blood (10 mL)	10–15 Working Days	4,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic mutations in the PIK3CA gene", "Variant allele frequency (down to 1%)"] Parameters [] Preparation [] Indications ["Diagnosis and treatment guidance for solid tumours", "Risk assessment for overgrowth syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 21626-4 ICD-10: Z15.09 Clinical summary This test evaluates the PIK3CA gene for somatic mutations using Next-Generation Sequencing (NGS). It identifies variants associated with solid tumours and overgrowth syndromes.
TEST-3864 PIK3R5 Gene Ataxia‑Oculomotor Apraxia Type 3 Genetic Test This test identifies pathogenic variants in the PIK3R5 gene, confirming a diagnosis of Ataxia-Oculomotor Apraxia Type 3 (AOA3).	Peripheral Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks (21–28 Business Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PIK3R5 gene"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session", "Three-generation pedigree chart required"] Indications ["Suspected Ataxia-Oculomotor Apraxia Type 3 (AOA3)", "Family history of AOA3"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G11.1 Clinical summary This test identifies pathogenic variants in the PIK3R5 gene, confirming a diagnosis of Ataxia-Oculomotor Apraxia Type 3 (AOA3).
TEST-3089 PITX2 Gene Axenfeld‑Rieger Syndrome Type 1 Genetic Test This genetic test analyzes the PITX2 gene to identify mutations associated with Axenfeld‑Rieger syndrome type 1.	Peripheral whole blood (3–5 mL in EDTA)	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PITX2 gene", "Copy-number variants (deletions/duplications) in the PITX2 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Suspicion of Axenfeld‑Rieger syndrome type 1", "Family history of Axenfeld‑Rieger syndrome", "Cascade screening for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 55131-5 ICD-10: Q13.8 Clinical summary This genetic test analyzes the PITX2 gene to identify mutations associated with Axenfeld‑Rieger syndrome type 1.
TEST-3081 PITX3 Gene Anterior Segment Mesenchymal Dysgenesis Genetic Test This test evaluates the PITX3 gene for pathogenic variants associated with anterior segment eye development disorders.	Peripheral whole blood (2-3 mL in EDTA)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PITX3 gene sequence", "Pathogenic variants", "Copy Number Variations (CNV)"] Parameters [] Preparation ["No fasting required", "No special diet required", "No medication withholding required"] Indications ["Diagnosis of suspected PITX3-related disorders", "Family planning risk assessment", "Guiding surgical timing"] Measurement technique Confirm with laboratory Codes LOINC: 21617-1 ICD-10: Q15.0, Q12.0, Q13.81 Clinical summary This test evaluates the PITX3 gene for pathogenic variants associated with anterior segment eye development disorders.
TEST-5670 PJVK Gene (DFNB59) Sequencing Test This test evaluates the PJVK gene for pathogenic variants associated with autosomal recessive non-syndromic sensorineural hearing loss (DFNB59).	Peripheral Whole Blood (3–5 mL EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PJVK gene", "Single-nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)", "Large structural rearrangements"] Parameters [] Preparation ["No specific fasting required", "Inform the phlebotomist of any medications being taken"] Indications ["Diagnosis of autosomal recessive non-syndromic sensorineural hearing loss (DFNB59)", "Family planning for individuals with a family history of DFNB59", "Carrier screening in families with a history of DFNB59"] Measurement technique Confirm with laboratory Codes LOINC: 48766-5 ICD-10: Z15.89, H90.3, Z13.71 Clinical summary This test evaluates the PJVK gene for pathogenic variants associated with autosomal recessive non-syndromic sensorineural hearing loss (DFNB59).
TEST-3541 PKHD1 Gene (Polycystic Kidney Disease Type 1, Autosomal Recessive) Genetic Test This test identifies pathogenic variants in the PKHD1 gene, confirming a diagnosis of Autosomal Recessive Polycystic Kidney Disease (ARPKD).	Peripheral whole blood (3–5 mL EDTA) or FTA card DNA specimen	3–4 Weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PKHD1 gene", "Exon and splice-site coverage of the PKHD1 gene"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist if on anticoagulant therapy", "Pre-test genetic counselling session required 24 hours prior to collection"] Indications ["Infants with enlarged echogenic kidneys", "Children presenting with portal hypertension or congenital hepatic fibrosis", "Adults with unexplained hepatorenal fibrocystic disease", "Individuals with a positive family history of ARPKD"] Measurement technique Confirm with laboratory Codes LOINC: 92547-4 ICD-10: Q61.1 Clinical summary This test identifies pathogenic variants in the PKHD1 gene, confirming a diagnosis of Autosomal Recessive Polycystic Kidney Disease (ARPKD).
TEST-3934 PKHD1L1 Gene Autism, PKHD1L1-related Genetic Test This test identifies genetic variants in the PKHD1L1 gene associated with autism spectrum disorders.	Whole blood (5 ml EDTA tube), FTA card dried blood spot, or extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PKHD1L1 gene", "Single-nucleotide variants", "Insertions", "Deletions", "Splice-site mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any known haematological disorders"] Indications ["Diagnosis of autism spectrum disorder", "Familial risk stratification", "Genetic counselling", "Cases where chromosomal microarray is negative"] Measurement technique Confirm with laboratory Codes LOINC: 94230-0 ICD-10: F84.0 Clinical summary This test identifies genetic variants in the PKHD1L1 gene associated with autism spectrum disorders.
TEST-3359 PKLR Gene Adenosine Triphosphate, Elevated Erythrocytes Genetic Test This genetic test analyzes the PKLR gene to identify mutations associated with pyruvate kinase deficiency, a cause of chronic hemolytic anemia.	Peripheral Whole Blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PKLR gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No fasting or special preparation required", "Mandatory pre-test genetic counselling session"] Indications ["Definitive molecular diagnosis of pyruvate kinase deficiency", "Carrier screening", "Informed genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 60230-6 ICD-10: D55.0 Clinical summary This genetic test analyzes the PKLR gene to identify mutations associated with pyruvate kinase deficiency, a cause of chronic hemolytic anemia.
TEST-5837 PKLR Gene Pyruvate Kinase Deficiency with Hemolytic Anemia Genetic Test This test identifies pathogenic variants in the PKLR gene associated with pyruvate kinase deficiency, a cause of hereditary non-spherocytic hemolytic anemia.	Peripheral Whole Blood (3–5 mL in EDTA), Extracted DNA, or FTA Card Dried Blood Spot	21–28 Calendar Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PKLR gene pathogenic variants", "Single nucleotide variants", "Small insertions and deletions", "Copy number changes"] Parameters [] Preparation ["No fasting required", "Inform collection team if on anticoagulant therapy"] Indications ["Diagnosis of hereditary non-spherocytic hemolytic anemia", "Carrier screening", "Family planning", "Risk stratification"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: D55.0 Clinical summary This test identifies pathogenic variants in the PKLR gene associated with pyruvate kinase deficiency, a cause of hereditary non-spherocytic hemolytic anemia.
TEST-4431 PKP2 Gene (Arrhythmogenic Right Ventricular Cardiomyopathy Type 9) Genetic Test This genetic test identifies pathogenic variants in the PKP2 gene associated with Arrhythmogenic Right Ventricular Cardiomyopathy Type 9 (ARVC9).	Whole blood (peripheral)	3–4 weeks (expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PKP2 gene sequence", "Copy Number Variations (CNVs) in PKP2"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any current anticoagulation therapy"] Indications ["Diagnosis of suspected ARVC9", "Family cascade screening for ARVC9", "Pre-sports clearance evaluation", "Risk stratification in individuals with unexplained cardiac symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 38177-0 ICD-10: I42.8 Clinical summary This genetic test identifies pathogenic variants in the PKP2 gene associated with Arrhythmogenic Right Ventricular Cardiomyopathy Type 9 (ARVC9).
TEST-3653 PLA2G5 Gene Familial Benign Fleck Retina Genetic Test This test evaluates the PLA2G5 gene for pathogenic variants associated with familial benign fleck retina.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PLA2G5 gene", "Genetic predisposition to familial benign fleck retina"] Parameters [] Preparation ["No fasting required", "No medication adjustments required"] Indications ["Suspected familial benign fleck retina", "Family history of inherited retinal dystrophy", "Genetic counseling for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 82326-5 ICD-10: H35.59 Clinical summary This test evaluates the PLA2G5 gene for pathogenic variants associated with familial benign fleck retina.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.